Dechao Jiao

4.4k total citations · 4 hit papers
142 papers, 3.1k citations indexed

About

Dechao Jiao is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Hepatology. According to data from OpenAlex, Dechao Jiao has authored 142 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pulmonary and Respiratory Medicine, 66 papers in Surgery and 36 papers in Hepatology. Recurrent topics in Dechao Jiao's work include Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers) and Tracheal and airway disorders (20 papers). Dechao Jiao is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers) and Tracheal and airway disorders (20 papers). Dechao Jiao collaborates with scholars based in China, United States and Senegal. Dechao Jiao's co-authors include Kongming Wu, Ming Yi, Xinwei Han, Hanxiao Xu, Qian Chu, Anping Li, Qian Liu, Shuang Qin, Weiheng Zhao and Xinwei Han and has published in prestigious journals such as ACS Nano, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Dechao Jiao

129 papers receiving 3.1k citations

Hit Papers

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors 2018 2026 2020 2023 2018 2019 2022 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    2018 573 citations Ming Yi, Dechao Jiao et al. Molecular Cancer profile →
  2. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
    2019 465 citations Ming Yi, Dechao Jiao et al. Molecular Cancer profile →
  3. Tumor organoids: applications in cancer modeling and potentials in precision medicine
    2022 161 citations Dechao Jiao, Kongming Wu et al. profile →
  4. Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
    2022 139 citations Ming Yi, Qian Chu et al. profile →

Peers

Dechao Jiao
Minoru Kitago Japan
Naomi Kiyota Japan
Joseph S. Palumbo United States
Yan‐Shen Shan Taiwan
Mariano Ponz‐Sarvisé Spain
Ming Zhang China
Kyu‐pyo Kim South Korea
Eva Lieto Italy
Mamoru Uemura Japan
John Slavin Australia
Minoru Kitago Japan
Dechao Jiao
Citations per year, relative to Dechao Jiao Dechao Jiao (= 1×) peers Minoru Kitago

Countries citing papers authored by Dechao Jiao

Since Specialization
Citations

This map shows the geographic impact of Dechao Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dechao Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dechao Jiao more than expected).

Fields of papers citing papers by Dechao Jiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dechao Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dechao Jiao. The network helps show where Dechao Jiao may publish in the future.

Co-authorship network of co-authors of Dechao Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Dechao Jiao. A scholar is included among the top collaborators of Dechao Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dechao Jiao. Dechao Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Teng, Yanxin Wang, Y. P. Chu, et al.. (2025). Paeoniflorin modulates AGEs/RAGE/P38MAPK/ERK/mTOR autophagy pathway to improve cognitive dysfunction in MRL/lpr mice. International Journal of Biological Macromolecules. 307(Pt 1). 141765–141765. 2 indexed citations
2.
Zhang, Chen‐Yu, Zhanguo Sun, Mengqiu Song, et al.. (2024). Effectiveness and safety of a ventricular septal occluder device for the treatment of Gastro-tracheal fistula. Clinical Radiology. 79(9). 697–703.
3.
4.
Li, Jing, Xueliang Zhou, Kunpeng Wu, et al.. (2024). N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1. Journal of Experimental & Clinical Cancer Research. 43(1). 119–119. 13 indexed citations
5.
Liu, Yiming, et al.. (2023). Percutaneous microwave ablation for lung tumors: a retrospective case-control study of conventional CT and C-arm CT guidance. Quantitative Imaging in Medicine and Surgery. 13(9). 5737–5747. 3 indexed citations
6.
Zhang, Chengzhi, et al.. (2023). Biliary drainage combined with simultaneous 125I seed strand brachytherapy for the treatment of hilar cholangiocarcinoma. BMC Cancer. 23(1). 418–418. 3 indexed citations
7.
8.
Zhao, Yanan, Zaoqu Liu, Kewei Ren, et al.. (2023). In Situ Nanofiber Patch Boosts Postoperative Hepatocellular Carcinoma Immune Activation by Trimodal Combination Therapy. ACS Nano. 18(1). 245–263. 7 indexed citations
9.
Liu, Zaoqu, Dechao Jiao, Long Liu, et al.. (2021). Development and validation of a robust immune-related risk signature for hepatocellular carcinoma. Medicine. 100(10). e24683–e24683. 8 indexed citations
10.
Zhou, Xueliang, Mengmeng Dou, Zaoqu Liu, et al.. (2021). Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma. Journal of Immunology Research. 2021. 1–20. 8 indexed citations
11.
Liu, Zaoqu, Long Liu, Taoyuan Lu, et al.. (2021). Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management. Journal of Oncology. 2021. 1–20. 27 indexed citations
12.
Liu, Zaoqu, Libo Wang, Chunguang Guo, et al.. (2021). TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer. Journal of Cellular and Molecular Medicine. 25(7). 3239–3251. 45 indexed citations
13.
Liu, Zaoqu, Taoyuan Lu, Yanli Wang, et al.. (2021). Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer. Journal of Cellular and Molecular Medicine. 25(14). 6874–6886. 33 indexed citations
14.
Wang, Libo, Zaoqu Liu, Long Liu, et al.. (2021). CELF2 is a candidate prognostic and immunotherapy biomarker in triple‐negative breast cancer and lung squamous cell carcinoma: A pan‐cancer analysis. Journal of Cellular and Molecular Medicine. 25(15). 7559–7574. 14 indexed citations
15.
Li, Zhaonan, Dechao Jiao, Xinwei Han, et al.. (2020). Portal Vein Stenting Combined with 125I Particle Chain Implantation Followed by As2O3 in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus. BioMed Research International. 2020(1). 4109216–4109216. 5 indexed citations
16.
Li, Zhaonan, Dechao Jiao, Xinwei Han, et al.. (2020). Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma. Cancer Imaging. 20(1). 13–13. 19 indexed citations
17.
Wang, Jing, Rong‐Rong He, Xinwei Han, et al.. (2019). High performance loose nanofiltration membranes obtained by a catechol-based route for efficient dye/salt separation. Chemical Engineering Journal. 375. 121982–121982. 127 indexed citations
18.
Yi, Ming, Dechao Jiao, Shuang Qin, et al.. (2019). Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment. Molecular Cancer. 18(1). 60–60. 465 indexed citations breakdown →
19.
20.
Jiao, Dechao, Xinwei Han, Ya-Feng Wang, et al.. (2012). Microwave Ablation Treatment of Liver Cancer with a 2,450-MHz Cooled-shaft Antenna: Pilot Study on Safety and Efficacy. Asian Pacific Journal of Cancer Prevention. 13(2). 737–742. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minoru Kitago Breakdown of academic impact, for papers by Naomi Kiyota Breakdown of academic impact, for papers by Joseph S. Palumbo Breakdown of academic impact, for papers by Yan‐Shen Shan Breakdown of academic impact, for papers by Mariano Ponz‐Sarvisé Breakdown of academic impact, for papers by Ming Zhang Breakdown of academic impact, for papers by Kyu‐pyo Kim Breakdown of academic impact, for papers by Eva Lieto Breakdown of academic impact, for papers by Mamoru Uemura Breakdown of academic impact, for papers by John Slavin
Rankless by CCL
2026